Which antibody class is the most common in mucosal secretions (saliva, tears, colostrum, and respiratory secretions) and provides the first line of defense against pathogens at mucosal surfaces?

Explanation

## IgA: The Mucosal Antibody **Key Point:** IgA is the most abundant antibody in the body by total mass and is the predominant immunoglobulin in mucosal secretions, providing critical defense at epithelial surfaces. ### IgA Structure and Distribution | Characteristic | Detail | |---|---| | **Total body abundance** | Highest by mass (~40% of total Ig produced daily) | | **Serum concentration** | 0.5–4 g/L (lower than IgG) | | **Secretory form** | Dimeric IgA (dIgA) + secretory component | | **Primary sites** | Saliva, tears, colostrum, respiratory/GI secretions | | **Molecular weight** | 160 kDa (dimer in secretions) | | **Half-life** | ~6 days | | **Complement activation** | Alternative pathway only (not classical) | ### Mechanism of Mucosal Immunity 1. **Production at MALT**: IgA is synthesized by plasma cells in mucosa-associated lymphoid tissue (MALT), including Peyer's patches, tonsils, and mesenteric lymph nodes. 2. **Transcytosis**: Dimeric IgA binds to the polymeric immunoglobulin receptor (pIgR) on epithelial cells and is transported across the epithelium. 3. **Secretory component**: The extracellular portion of pIgR remains bound to IgA, forming secretory IgA (sIgA), which protects the antibody from proteolytic degradation. 4. **Functional outcome**: sIgA prevents pathogen adhesion, neutralizes toxins, and promotes immune exclusion without triggering inflammation. **High-Yield:** Colostrum (first milk) is rich in IgA, providing passive immunity to the newborn's mucosal surfaces (GI tract) during the critical first weeks of life — this is distinct from IgG placental transfer, which protects systemic immunity. **Clinical Pearl:** Deficiency of IgA (selective IgA deficiency) is the most common primary immunodeficiency in developed countries and often presents with recurrent mucosal infections (sinusitis, otitis media, bronchitis). ### Why IgA, Not IgG, at Mucosal Sites - **IgG** is abundant in serum but does not efficiently reach mucosal secretions; it requires specific transport mechanisms and is not the primary mucosal antibody. - **IgM** is produced early in infection but is not adapted for mucosal secretion and cannot cross the epithelium efficiently. - **IgD** is a membrane-bound receptor on B cells, not a secreted antibody, and plays no role in mucosal defense. **Mnemonic:** **MALT-IgA** — Mucosa-Associated Lymphoid Tissue produces IgA for mucosal Antigen-specific defense. [cite:Kuby Immunology 8e Ch 5]